Handelsinvest Investeringsforvaltning - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.

Quarter-by-quarter ownership
Handelsinvest Investeringsforvaltning ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q1 2022$5,336,000
-22.6%
45,000
-10.0%
0.65%
-7.7%
Q4 2021$6,891,000
-0.8%
50,0000.0%0.70%
-7.7%
Q3 2021$6,946,000
+43.1%
50,0000.0%0.76%
+40.4%
Q2 2021$4,854,000
+42.0%
50,0000.0%0.54%
+29.5%
Q1 2021$3,418,000
-11.4%
50,000
+11.1%
0.42%
-27.2%
Q4 2020$3,857,000
+48.3%
45,000
+12.5%
0.57%
+16.0%
Q3 2020$2,600,000
-11.1%
40,0000.0%0.49%
-18.5%
Q2 2020$2,924,000
+114.8%
40,0000.0%0.61%
+67.9%
Q1 2020$1,361,000
-37.5%
40,0000.0%0.36%
-17.0%
Q4 2019$2,178,000
+30.5%
40,0000.0%0.44%
+18.5%
Q3 2019$1,669,000
+90.5%
40,000
+100.0%
0.37%
+99.5%
Q2 2019$876,00020,0000.18%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 710,422$24,658,74716.62%
Birchview Capital, LP 7,365$255,6390.24%
Itau Unibanco Holding S.A. 88$3,0540.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders